scholarly journals Examination of the Relationship Between PTSD and Distress Tolerance in a Sample of Male Veterans With Comorbid Substance Use Disorders

2016 ◽  
Vol 28 (2) ◽  
pp. 104-114 ◽  
Author(s):  
Christine Vinci ◽  
Natalie Mota ◽  
Erin Berenz ◽  
Kevin Connolly
2016 ◽  
Vol 30 (1) ◽  
pp. 50-59 ◽  
Author(s):  
Lauren P. Greenberg ◽  
Sarah L. Martindale ◽  
Laura R. Fils-Aimé ◽  
Sara L. Dolan

Impulsivity and distress tolerance (DT) have been implicated as key features in development and maintenance of substance use disorders. This study expanded on previous research by exploring the four factors of DT (Absorption, Appraisal, Regulation, Tolerance) and their interaction with impulsivity in relation to substance use. Participants were 105 men and 150 women who completed measures of impulsivity, DT, and substance use. Results indicated that Appraisal DT was a better predictor of substance use problems over and above overall DT or other DT factors. Mediation analysis indicated that Appraisal partially mediated the relationship between impulsivity and DT. Results suggest that DT, particularly Appraisal, plays a role in substance use problems, specifically in the relationship between impulsivity and substance use problems. Treatments emphasizing DT skills, particularly the appraisal of aversive emotions, may be useful to employ when attempting to reduce harmful drinking or drug use behaviors.


2010 ◽  
Vol 15 (8) ◽  
pp. 1829-1833 ◽  
Author(s):  
Christina S. Meade ◽  
Garrett M. Fitzmaurice ◽  
Amy K. Sanchez ◽  
Margaret L. Griffin ◽  
Leah J. McDonald ◽  
...  

Author(s):  
S. Janet Kuramoto-Crawford ◽  
Holly C. Wilcox

Intentional injuries affect millions of lives worldwide. The authors provide an overview of the epidemiological and preventive evidence on the relationship between substance use disorders (SUD) and intentional injuries. Emphasis is placed on suicide and intimate partner violence, as each area has received substantial research attention in relation to SUD. There is robust epidemiological evidence on the relationship between SUD, notably with alcohol use disorders, and most intentional injuries. Research has focused on the identification of factors that distinguish individuals with alcohol use disorders who are at particularly high risk for intentional injuries. Characterization of those with other drug use disorders who are at risk for engaging in intentional injuries and the role of SUD in intentional injuries has been less extensively investigated. The authors conclude with a discussion of public health approaches to the prevention of intentional injuries among individuals with SUD.


2002 ◽  
Vol 43 (4) ◽  
pp. 245-252 ◽  
Author(s):  
Renee D. Goodwin ◽  
David A. Stayner ◽  
Matthew J. Chinman ◽  
Ping Wu ◽  
Jacob Kraemer Tebes ◽  
...  

2014 ◽  
Vol 140 ◽  
pp. e112-e113
Author(s):  
Magdalena Kulesza ◽  
S.E. Ramsey ◽  
R. Brown ◽  
M.E. Larimer

2019 ◽  
Vol 8 (7) ◽  
pp. 1058 ◽  
Author(s):  
Albert Batalla ◽  
Hella Janssen ◽  
Shiral S. Gangadin ◽  
Matthijs G. Bossong

The endogenous cannabinoid (eCB) system plays an important role in the pathophysiology of both psychotic disorders and substance use disorders (SUDs). The non-psychoactive cannabinoid compound, cannabidiol (CBD) is a highly promising tool in the treatment of both disorders. Here we review human clinical studies that investigated the efficacy of CBD treatment for schizophrenia, substance use disorders, and their comorbidity. In particular, we examined possible profiles of patients who may benefit the most from CBD treatment. CBD, either as monotherapy or added to regular antipsychotic medication, improved symptoms in patients with schizophrenia, with particularly promising effects in the early stages of illness. A potential biomarker is the level of anandamide in blood. CBD and THC mixtures showed positive effects in reducing short-term withdrawal and craving in cannabis use disorders. Studies on schizophrenia and comorbid substance use are lacking. Future studies should focus on the effects of CBD on psychotic disorders in different stages of illness, together with the effects on comorbid substance use. These studies should use standardized measures to assess cannabis use. In addition, future efforts should be taken to study the relationship between the eCB system, GABA/glutamate, and the immune system to reveal the underlying neurobiology of the effects of CBD.


Sign in / Sign up

Export Citation Format

Share Document